PIK3CA and small cell lung carcinoma: Yamamoto et al. were not able to identify PIK3CA mutations in SCLC cell lines, but reported PIK3CA copy number gains, associated with increased expression of activated Akt, also identified in 33.1% of squamous cell lung cancer and 6.2% of lung adenocarcinomas [29].